Farobact
✅ Fights bacterial infections
✅ Enhances immune response
✅ Reduces inflammation
✅ Promotes faster recovery
✅ Safe for consumption
✓ Ιατρικά ελεγμένο από Morgan Ellis — Ερευνητής Φαρμακευτικής · 8 χρόνια εμπειρία · Τελευταία αναθεώρηση: Μάιος 2026
⚡ Quick Answer — What is Farobact?
Farobact is a faropenem tablet (200 mg / 300 mg, Cipla) — an oral penem antibiotic with broad coverage including some beta-lactamase-producing pathogens. Reserve for documented resistant infections — routine use accelerates resistance to last-line carbapenems.
📦 Κάθε παραγγελία καλύπτεται από την Πολιτική Εγγύησης Επαναποστολής — εάν το δέμα σας δεν φτάσει εντός 20 εργάσιμων ημερών, το επαναποστέλλουμε.
Γιατί να παραγγείλετε από τη MedsBase
Τα γενόσημα φάρμακά μας προέρχονται από κατασκευαστές που πιστοποιούνται από την WHO-GMP και αποστέλλονται παγκοσμίως σε διακριτική, απλή συσκευασία — χωρίς όνομα φαρμάκου στο εξωτερικό του δέματος. Οι πληρωμές με κάρτα δρομολογούνται μέσω ρυθμισμένου επεξεργαστή (οι περιγραφές εκκαθάρισης περιλαμβάνουν ρυθμισμένο επεξεργαστή πληρωμών με κάρτα — ποτέ “MedsBase” ή οποιοδήποτε όνομα φαρμάκου). Γίνονται δεκτές και πληρωμές με κρυπτονομίσματα και τραπεζική μεταφορά SEPA. Κάθε παραγγελία καλύπτεται από την Πολιτική Επαναποστολής Εξασφαλίσεώς μας.
How Farobact works
Farobact contains faropenem sodium, an oral penem antibiotic structurally related to carbapenems but more stable to many beta-lactamases. It binds penicillin-binding proteins to inhibit bacterial cell-wall synthesis. Spectrum is broad: most Streptococci, methicillin-sensitive Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis, Enterobacteriaceae (including some ESBL producers), and oral anaerobes. It is NOT active against Pseudomonas, MRSA, or carbapenem-resistant Enterobacteriaceae. Faropenem has fairly broad approval in India and Japan but limited regulatory presence in the US and EU.
Faropenem is structurally related to carbapenems and shares some resistance mechanisms. Routine use for uncomplicated infections that respond to amoxicillin / co-amoxiclav / cephalosporins is strongly discouraged — it accelerates resistance to last-line carbapenems used for ESBL and MDR infection. Reserve faropenem for documented β-lactamase-producing pathogens unresponsive to first-line agents, and only after culture-guided decision-making.
Indications & dosing
| Ενδείξεις | Δόση | Διάρκεια |
|---|---|---|
| Acute bacterial sinusitis / otitis media (resistant) | 300 mg three times daily | 7–10 days |
| Mild–moderate community-acquired pneumonia (resistant or amoxiclav-failure) | 300 mg three times daily | 7–14 days |
| Complicated UTI (sensitive) | 300 mg three times daily | 7–14 days |
| Uncomplicated skin / soft-tissue infection | 300 mg three times daily | 7–14 days |
Take with food to reduce gastrointestinal side effects. Renal dose adjustment in CrCl < 30.
Παρενέργειες
- Diarrhoea (most common, ~10%); nausea, abdominal pain.
- Hypersensitivity — rash, urticaria, anaphylaxis (cross-reactive with penicillins / cephalosporins / carbapenems).
- C. difficile colitis.
- Liver enzyme elevation (rare).
- Vaginal / oral candidiasis.
Αντενδείξεις
- Known beta-lactam (penicillin / cephalosporin / carbapenem) anaphylaxis.
- Severe renal impairment without dose adjustment.
- Children < 6 months — limited safety data.
Αλληλεπιδράσεις φαρμάκων
| Φάρμακο | Αποτέλεσμα | Action |
|---|---|---|
| Προβενεσίδη | Raises serum levels | No routine adjustment |
| Valproate | Carbapenem class lowers valproate levels — faropenem may share this effect | Avoid combination |
| Βαρφαρίνη | Variable INR effect | Check INR mid-course |
Pregnancy & Breastfeeding
Limited human pregnancy data. Use in pregnancy and breastfeeding only when alternatives are unavailable.
Αποθήκευση
Store below 25 °C, away from direct sunlight and moisture. Keep in original packaging. Keep out of reach of children. Discard any unused tablets after the printed expiry date — degraded antibiotics can lose potency or release breakdown products.
This medicine is only effective against bacterial infections. Do not use it for viral illnesses (common cold, most sore throats, flu, COVID-19), do not stop early when you feel better, and do not save leftovers for future infections. Misuse drives drug-resistant bacteria like MRSA, ESBL, and CRE — the WHO ranks antimicrobial resistance among the top 10 global public-health threats.
Συχνές Ερωτήσεις
Why is faropenem not first-line for an ordinary infection?
Faropenem is in the carbapenem-related class. Routine use for infections that would respond to amoxicillin or co-amoxiclav drives resistance to carbapenems — last-line agents for life-threatening Gram-negative infection. Reserve for documented resistant pathogens.
How is it different from a regular oral antibiotic?
Faropenem has broader Gram-negative cover than amoxicillin and resists many beta-lactamases that destroy amoxicillin / first-generation cephalosporins. Trade-off: higher resistance pressure on the carbapenem class.
Should I take it with food?
Yes — taking with food reduces nausea and slightly slows but does not reduce overall absorption.
Will it cover Pseudomonas?
No. Faropenem has no useful Pseudomonas activity.
Will it cover MRSA?
No. Use clindamycin / doxycycline / TMP-SMX / linezolid based on local susceptibility data.
Can I take it if I am penicillin-allergic?
Cross-reactivity exists across the entire beta-lactam class. With anaphylactic penicillin allergy, avoid faropenem. With mild delayed rashes, discuss with a clinician — penem use may be acceptable under specialist guidance.
How long should treatment last?
Most respiratory and urinary indications use 7–14 days. Short courses (5 days) are rarely supported by trial data.
Μπορώ να πίνω αλκοόλ;
No direct interaction. Light social use is fine; binge drinking weakens immune response.
Will it interact with my warfarin?
Possibly — INR can shift in either direction. Check INR within 3–5 days and counsel on bleeding signs.
Why is faropenem more available in India / Japan than in the US?
Faropenem completed Phase III trials in the US but the FDA requested additional non-inferiority data versus standard-of-care comparators. It remains widely used in India and parts of Asia, where local susceptibility patterns and prescribing culture differ.
Other Antibiotics & Anti-Infective Medications
- Augmentin (Amoxicillin + Clavulanic acid) — beta-lactam alternative
- Azee (Azithromycin) — atypical-pathogen cover
- Levomac (Levofloxacin) — respiratory fluoroquinolone
- Doxt (Doxycycline) — atypical pneumonia / STIs
- Mox (Amoxicillin) — first-line for many community infections
More options in Antibiotics
Ταξινομημένα σύμφωνα με τον όγκο παραγγελιών στο MedsBase — τι επιλέγουν άλλοι πελάτες σε αυτήν την κατηγορία.
| Ισχύς | 200 mg, 300 mg |
|---|---|
| Ποσότητα | 12 Bottle/s, 24 Tablet/s, 48 Tablet/s |
| Φαρμακευτική Μορφή | Δισκία |
| Κατασκευαστής | Cipla Inc |
| Θεραπεία | Serious bacterial infections |
| Γενόσημη μάρκα | Faropenem |
Farobact
Ερωτήσεις & Απαντήσεις
Farobact
Σχετικά προϊόντα
Κριτικές
Δεν υπάρχουν ακόμη κριτικές